Copyright
©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 105332
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.105332
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.105332
Figure 2 Screening of candidate diagnostic biomarkers in sarcopenic cirrhotic patients.
A: Coefficient profile plot of the Least Absolute Shrinkage and Selection Operator model for cirrhotic patients with sarcopenia showed the final parameter selection l (lambda); B: Top-10 biomarkers based on their discriminant ability in the Support Vector Machine-Recursive Feature Elimination algorithm; C: Top-10 biomarkers selected by using the random forest algorithm; D: The Venn diagram for four candidate metabolic biomarkers in sarcopenic cirrhotic patients by intersecting the results of three algorithms. LASSO: Least Absolute Shrinkage and Selection Operator; RF: Random Forest; SVM-RFE: Support Vector Machine-Recursive Feature Elimination.
- Citation: Liang QY, Wang J, Yang YF, Zhao K, Luo RL, Tian Y, Li FX. Machine learning to identify potential biomarkers for sarcopenia in liver cirrhosis. World J Hepatol 2025; 17(6): 105332
- URL: https://www.wjgnet.com/1948-5182/full/v17/i6/105332.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i6.105332